Stan Smith - Dec 30, 2022 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Stock symbol
MAIA
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:50 PM
Previous filing
Jan 3, 2023
Next filing
Jan 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Stock Options Award $0 +3.81K $0.00 3.81K Dec 30, 2022 Common Stock 3.81K $3.51 see footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options, granted on December 30, 2022 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.